<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2013</study_start_year><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2149306</full_dataset_link><location>China</location><study_start_month>8</study_start_month><keyword>Bevacizumab</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer</name><description>To assess the safety profile of bevacizumab in combination with chemotherapy for the treatment of metastatic colorectal cancer</description><dates><creation>2013-08-15</creation></dates><accession>2149306</accession><cross_references><ClinicalTrials___gov>NCT01912443</ClinicalTrials___gov></cross_references></HashMap>